Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 09 10 2020
accepted: 16 02 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 5 5 2021
Statut: epublish

Résumé

The COVID-19 pandemic has intensely changed the everyday lives of people worldwide. This study explores the forms and outcomes of coronavirus and COVID-19-related social stigma and the experiences of people who were home quarantined or isolated in Finland during the spring 2020. The findings of this study can be used to improve support for those quarantined or isolated and to develop strategies to reduce the stigma associated with coronavirus and COVID-19. The study is based on qualitative one-to-one interviews with households with at least two members and at least one PCR confirmed COVID-19 case. Recruitment took place via website or SMS messages sent to PCR confirmed cases in the capital area of Helsinki. Sampling was based on maximum variation to acquire different types of respondents. The framework of health stigma was used to develop question guides and analyze stigma. Quarantine and isolation experiences were explored through open-ended questions. The analysis was based on thematic analysis. The study included 64 participants from 24 households. Perceived stigma among respondents was driven by fear and blame for infection, and it manifested in various ways leading to a reluctance to disclose their coronavirus status to others. Self-stigma developed from conflicting information and advice about coronavirus and COVID-19 led to difficulties interacting with others outside of the house and reluctance to meet people after quarantine and isolation. Quarantine and isolation experiences included uncertainty, health concerns, and boredom. Communication with others in similar situations was perceived vital, whereas discussions with family members about worries and fears related to coronavirus and COVID-19 was not preferred. This study shed light on the lives of those quarantined or isolated at home and provided a set of operational recommendations to minimize coronavirus and COVID-19-associated stigma and to reduce challenges faced by those in quarantine or isolation.

Sections du résumé

BACKGROUND
The COVID-19 pandemic has intensely changed the everyday lives of people worldwide. This study explores the forms and outcomes of coronavirus and COVID-19-related social stigma and the experiences of people who were home quarantined or isolated in Finland during the spring 2020. The findings of this study can be used to improve support for those quarantined or isolated and to develop strategies to reduce the stigma associated with coronavirus and COVID-19.
METHODS
The study is based on qualitative one-to-one interviews with households with at least two members and at least one PCR confirmed COVID-19 case. Recruitment took place via website or SMS messages sent to PCR confirmed cases in the capital area of Helsinki. Sampling was based on maximum variation to acquire different types of respondents. The framework of health stigma was used to develop question guides and analyze stigma. Quarantine and isolation experiences were explored through open-ended questions. The analysis was based on thematic analysis.
RESULTS
The study included 64 participants from 24 households. Perceived stigma among respondents was driven by fear and blame for infection, and it manifested in various ways leading to a reluctance to disclose their coronavirus status to others. Self-stigma developed from conflicting information and advice about coronavirus and COVID-19 led to difficulties interacting with others outside of the house and reluctance to meet people after quarantine and isolation. Quarantine and isolation experiences included uncertainty, health concerns, and boredom. Communication with others in similar situations was perceived vital, whereas discussions with family members about worries and fears related to coronavirus and COVID-19 was not preferred.
CONCLUSIONS
This study shed light on the lives of those quarantined or isolated at home and provided a set of operational recommendations to minimize coronavirus and COVID-19-associated stigma and to reduce challenges faced by those in quarantine or isolation.

Identifiants

pubmed: 33852581
doi: 10.1371/journal.pone.0247962
pii: PONE-D-20-28826
pmc: PMC8046198
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0247962

Déclaration de conflit d'intérêts

No authors have no competing interest.

Références

Soc Sci Humanit Open. 2020;2(1):100045
pubmed: 34173490
Nat Hum Behav. 2020 May;4(5):460-471
pubmed: 32355299
Int J Environ Res Public Health. 2020 Apr 26;17(9):
pubmed: 32357424
Clin Infect Dis. 2021 Feb 16;72(4):697-702
pubmed: 32544242
J Travel Med. 2020 May 18;27(3):
pubmed: 32167146
Gen Hosp Psychiatry. 2020 Sep - Oct;66:81-88
pubmed: 32736195
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32631833
Am Psychol. 2004 Oct;59(7):614-625
pubmed: 15491256
Am J Infect Control. 2010 May;38(4):302-7
pubmed: 20083327
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
PLoS One. 2020 Jul 2;15(7):e0235590
pubmed: 32614889
N Engl J Med. 2004 Jun 3;350(23):2352-61
pubmed: 15175437
Healthcare (Basel). 2020 Jun 12;8(2):
pubmed: 32545647
Ann Acad Med Singap. 2006 May;35(5):301-16
pubmed: 16829997
Lancet. 2020 Apr 4;395(10230):1109-1110
pubmed: 32199470
Am J Public Health. 2013 May;103(5):813-21
pubmed: 23488505
Am Fam Physician. 2011 Oct 1;84(7):780-4
pubmed: 22010616
PLoS Med. 2011 Nov;8(11):e1001124
pubmed: 22131907
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Trop Med Int Health. 2009 Nov;14 Suppl 1:101-4
pubmed: 19814764
Can J Psychiatry. 2017 Oct;62(10):702-715
pubmed: 28622747
Lancet Infect Dis. 2020 May;20(5):e102-e107
pubmed: 32145768
Psychol Health Med. 2006 Aug;11(3):353-63
pubmed: 17130071
Lancet Infect Dis. 2020 Jul;20(7):782
pubmed: 32592670
Patient Educ Couns. 2017 Nov;100(11):2106-2108
pubmed: 28637611
Soc Sci Med. 2003 Jul;57(1):13-24
pubmed: 12753813
Virtual Mentor. 2010 Mar 01;12(3):225-30
pubmed: 23140873
J Transcult Nurs. 2020 Jul;31(4):326-332
pubmed: 32316872
PLoS One. 2020 May 29;15(5):e0233874
pubmed: 32470088
Obesity (Silver Spring). 2020 Jul;28(7):1180-1181
pubmed: 32324954
J Med Internet Res. 2020 May 6;22(5):e19301
pubmed: 32343669
PLoS One. 2020 May 21;15(5):e0233744
pubmed: 32437432
Epilepsy Behav. 2003 Jun;4(3):259-67
pubmed: 12791327
Prim Health Care Res Dev. 2015 Nov;16(6):618-22
pubmed: 25660904
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
BMC Public Health. 2009 Dec 16;9:470
pubmed: 20015400
Math Biosci Eng. 2020 Mar 11;17(3):2725-2740
pubmed: 32233563
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265005
AIDS. 2008 Aug;22 Suppl 2:S67-79
pubmed: 18641472
J Nurs Scholarsh. 2005;37(4):343-7
pubmed: 16396407

Auteurs

Anna-Leena Lohiniva (AL)

The Finnish Institute for Health and Welfare, Helsinki, Finland.

Timothee Dub (T)

The Finnish Institute for Health and Welfare, Helsinki, Finland.

Lotta Hagberg (L)

The Finnish Institute for Health and Welfare, Helsinki, Finland.

Hanna Nohynek (H)

The Finnish Institute for Health and Welfare, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH